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  T
he modern concept of a 
social stigma comes from the 
work of American sociologist 
Erving Goffman, who described it as 
a response to a deeply discrediting 
attribute that devalues the person 
[1]. In the medical literature, stigma 
is almost inevitably written about in 
terms of adverse social sequelae of a 
disease—such as leprosy, tuberculosis, 
epilepsy, schizophrenia, or ﬁ  lariasis 
[2–6]—or a physical characteristic 
or functional loss, such as obesity, 
deafness, or paraplegia [7–9]. The 
consequences of stigma range from 
moderate opprobrium at one end of 
the spectrum to death [10].
    The Role of Stigma in Society
    But is stigma always bad for health? 
Recent research has begun to move 
beyond the generally descriptive work 
that has populated the ﬁ  eld to consider 
the possible social and biological 
functions of stigma [11,12]. This new 
research has broadened the focus from 
a singular interest in those who are 
stigmatised, and the negative effects 
this has on their lives, to the role of 
stigma within a population. 
    When considered at a population 
level, stigma can be studied as an 
enduring social process, which 
inevitably produces negative outcomes 
for some individuals but might in 
some circumstances produce positive 
outcomes for a population. The 
orchestrated stigmatisation of smoking 
is a case in point. It appears to reduce 
the population burden of mortality 
and morbidity due to tobacco by 
encouraging some to quit (or never to 
smoke), although it leaves “recalcitrant” 
smokers more marginalised by their 
continued habit [13,14].
    The Stigma of HIV
    On any ranked list of stigmatised 
conditions, HIV would have to lie 
towards the top. As a global public 
health issue, HIV remains a huge 
priority. In 2005, it was estimated 
that 40.3 million people were living 
with HIV/AIDS, 4.9 million had 
newly acquired infections, and 3.1 
million had died [15]. The delivery 
of antiretroviral therapy to everyone 
infected and the development of new 
antiretroviral therapies are critical to 
controlling the epidemic. But equally 
important is the prevention of new 
infections.
    In 2002, the Joint United Nations 
Programme on HIV/AIDS (UNAIDS) 
published a report declaring that the 
stigma associated with HIV was one of 
the “greatest barriers” to preventing new 
infections and alleviating the impact of 
the disease [16]. In other words, stigma 
is one of the major determinants of the 
trajectory of the epidemic. For UNAIDS 
to make such a declaration, one would 
expect there to be a considerable body 
of evidence to back its position. Such 
a statement naturally suggests that 
combating the stigma associated with 
HIV is worthy of substantial economic 
and human investment.
    In the four years since the report 
was published, the UNAIDS position 
has remained consistent [17], and 
is also now well reﬂ  ected within the 
World Health Organization (WHO) 
[18]. The UNAIDS position, however, 
is complicated. In addition to being a 
determinant of the global epidemic, 
UNAIDS also argues that HIV-related 
stigma is one of the greatest barriers to 
the provision of treatment, care, and 
support to people living with HIV/
AIDS (PLWHA). A typical description 
of this relationship is as follows: 
“Stigma and discrimination both stymie 
efforts to control the global epidemic 
and create an ideal climate for further 
growth. Together, they constitute one 
of the greatest barriers to preventing 
further infections, providing adequate 
care, support and treatment, and 
alleviating the epidemic’s impact” [19].
    The two claims are semantically and 
epidemiologically bound together. 
The ﬁ  rst claim is that stigma is a 
determinant of the global epidemic. 
The second is that stigma adversely 
affects the lives of PLWHA. The 
second claim is uncontroversial, 
and is supported by considerable 
empirical evidence showing that stigma 
exacerbates the already-heavy burden 
experienced by PLWHA. Stigma can 
affect areas of life as diverse as housing, 
employment, education, and most 
critically, access to health care [20].
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    Where Is the Evidence That Stigma 
Fuels the Epidemic?
    The ﬁ  rst claim, linking HIV stigma and 
the global epidemic, is also treated as a 
fact—so notorious that it has become 
the basis for considerable policy and 
program development [16,21]. The 
actual evidence base, however, is 
almost nonexistent. In spite of this 
lack of evidence, the idea is repeated 
like a shibboleth [21–31]. With each 
repetition, its veracity appears to 
increase.
    The argument for the link between 
HIV stigma and the global epidemic 
goes something like this: stigma 
undermines HIV prevention efforts 
by making a person afraid to engage 
in safe behaviour or seek testing for 
fear that these acts would themselves 
raise suspicion in the minds of others 
about the person’s HIV sero-status 
[21]. Stigma leads to fear, fear leads 
to unsafe behaviour, and unsafe 
behaviour leads to the spread of the 
infection in the population (Figure 1).
    This line of reasoning about the 
relationship between stigma and the 
spread of HIV in the population is 
ﬂ  awed in two ways. The ﬁ  rst ﬂ  aw is 
that it ignores the nonlinear dynamics 
of infectious disease transmission in 
populations [32–34]. HIV spreads by 
exploiting a few human behaviours, 
predominantly sexual intercourse 
and injection-drug use. Both of these 
behaviours are associated with a high 
degree of cultural speciﬁ  city with 
respect to who engages in them, who 
they engage with, and the periods of 
their lives during which they engage—
these are the factors that largely 
determine the spread of the infection. 
For this reason, the virus generally 
takes hold in subpopulations ﬁ  rst, such 
as injection-drug users, commercial sex 
workers, men who have sex with men, 
and mobile populations [35,36].
    Even if stigma does increase the risk 
of infection within high-risk groups, it 
could simultaneously slow the spread 
of infection from those groups to the 
general population. Objectionable 
as it may be to see a lethal infection 
spread in any part of a population, 
uncontained spread within a part of the 
population is better than uncontained 
spread within the whole population. 
It is plausible that a social control 
mechanism, such as stigma, could 
reduce opportunities for contact 
between high- and low-risk groups. 
All other things being equal, under 
these conditions the spread of the virus 
across the whole population would 
be slowed. We are thus suggesting an 
alternative hypothesis to the UNAIDS 
position.
    The second problem with the 
claimed relationship between 
stigma and the spread of HIV is a 
measurement issue. To establish 
a causal link between HIV stigma 
and epidemic progression requires 
longitudinal data on rates of infection 
and levels of HIV stigma. Weaker, but 
nonetheless potentially persuasive, 
evidence could also be found in an 
observed correlation between levels of 
HIV-related stigma and rates of HIV 
infection across contexts—such as 
between countries. Currently, no such 
evidence is available. 
    The best supporting evidence comes 
out of studies such as those recently 
undertaken in China with mobile 
populations in which an association 
was found between increased levels of 
stigmatising attitudes toward PLWHA 
and a reported unwillingness to 
engage in harm-reduction activities 
[37,38]. Unfortunately, such studies 
tend to focus only on the spread of 
infection within particular high-risk 
subpopulations, and cannot address 
the question of interaction between 
populations. Solving the measurement 
problem requires, among other 
things, good estimates of the rate 
of new infections in populations 
and subpopulations, and a clear 
understanding of what “HIV stigma” 
really means.
    Data on new HIV infections are 
sparse. Indeed, UNAIDS itself only 
reports country estimates of prevalence 
[15]. Without data on new infections, 
however, it is hard to establish 
the correctness of the UNAIDS 
position. Even where incidence data 
are available, they often focus on 
subpopulations rather than whole 
populations, and this again misses the 
point about the possible relationship 
between a social process such as 
stigmatisation and the spread of HIV in 
the population [39,40].
    It is also difﬁ  cult to know what 
exactly is meant, for measurement or 
intervention purposes, by “HIV stigma” 
or “HIV-related stigma”. It is not a 
singular entity. HIV stigma is bound up 
with pre-existing stigmatising attributes 
including commercial sex work and 
injection-drug use [41]. The stigma of 
one is conﬂ  ated with the stigma of the 
others [11]. Separating the effect of 
pre-existing stigmas from the stigma of 
the disease alone is important for the 
development of interventions and for 
the identiﬁ  cation of priorities.
    In writing this Essay, our aim is 
neither to diminish the suffering of 
PLWHA in the eyes of the reader nor 
to advocate for the use of HIV stigma 
as a mechanism to control the spread 
of the epidemic. Our objective was to 
draw attention to the lack of evidence 
supporting the current dominant view 
on the relationship between stigma and 
the global spread of HIV. As a driver of 
policy, the current position closes down 
potentially important lines of scientiﬁ  c 
inquiry. Stigma and epidemic control 
may in fact be two separate problems, 
but the current position conﬂ  ates 
them and halts any consideration of 
potentially fruitful ways of dealing with 
them as individual issues.
  Conclusion
    Blaming stigma gives too much weight 
to individual behavioural change as the 
answer to HIV prevention: stigmatise 
PLWHA less and engage in harm-
reduction behaviours more. It neglects 
the more-difﬁ  cult issues relating to 
the manner in which HIV spreads in 
populations, the social vulnerabilities 
it exploits, and the ways in which 
individuals within subpopulations 
interact with each other and with 
members of other subpopulations.
    There are some core scientiﬁ  c 
issues that need to be overcome if the 
question of the relationship between 
HIV stigma and the spread of HIV is to 
be resolved. Whether HIV stigma is one 
of the greatest barriers to the global 
control of the epidemic remains a 
hypothesis. The scientiﬁ  c investigation 
of it demands signiﬁ  cant effort, and 
should be a matter of priority.   
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